Suppression of murine type-C RNA virogenes by type-specific oncornavirus vaccines: prospects for prevention of cancer.
- 1 February 1976
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 73 (2) , 620-624
- https://doi.org/10.1073/pnas.73.2.620
Abstract
Immunization of crossbred and F1 mice with combined killed and live Gross leukemia virus AKR type-C viral vaccines suppressed endogeneous N-type AKR virus up to 10,000-fold for significant periods during early life. Since several previous studies in the same and similar crossbred systems revealed direct correlations between low and high levels of type-C virus early in life with low and high incidences of leukemia and other cancers later in life, we believe that prospects for suppression of spontaneous neoplasms are good; however, 8-14 months will be required to achieve the final results. Should cancers be prevented by serotype-specific vaccines, such evidence would provide conclusive proof of endogenous viral etiology.Keywords
This publication has 26 references indexed in Scilit:
- Naturally occurring cytotoxic tumour reactive antibodies directed against type C viral envelope antigensNature, 1975
- Properties of mouse leukemia virusesVirology, 1975
- Clonal cell lines from a feral mouse embryo which lack host-range restrictions for murine leukemia virusesVirology, 1975
- AUTOGENOUS IMMUNITY TO ENDOGENOUS RNA TUMOR VIRUSThe Journal of Experimental Medicine, 1974
- Inhibition of Chemical Carcinogenesis by Viral VaccinesScience, 1972
- Plaque assay techniques for murine leukemia virusesVirology, 1970
- Demonstration of Biological Activity of a Murine Leukemia Virus of New Zealand Black MiceScience, 1970
- Mouse Leukemia Virus Activation by Chemical CarcinogensScience, 1969
- Passive and Active Immunity to Friend Virus DiseaseNature, 1966
- IMMUNOLOGICAL RELATIONSHIPS OF A FILTERABLE AGENT CAUSING A LEUKEMIA IN ADULT MICEThe Journal of Experimental Medicine, 1959